Tag: Drug shortage

For many patients relying on it for glaucoma treatment, dorzolamide has been subject to frustrating and sudden shortages in recent years. These supply chain disruptions, impacting a widely used generic drug, highlight a fragile pharmaceutical ecosystem. A complex mix of economic pressures, manufacturing challenges, and market forces makes it hard to get dorzolamide, putting patient care at risk.

Drug shortages reached a record high in the first quarter of 2024, with 323 active medication shortages, impacting countless patients [1.3.2, 1.3.7]. Knowing what to do when the pharmacy is out of stock of your prescription is a crucial skill for managing your health.

In the United States, approximately 30.6 million adults report using benzodiazepines like clonazepam [1.7.2]. As of 2025, the question 'Is there a shortage of clonazepam?' has become a critical concern for many, with some manufacturers reporting supply issues due to increased demand [1.2.1].

Between January 2021 and December 2023, prescriptions for semaglutide, the active ingredient in Ozempic, increased by 442% [1.3.3]. This incredible surge in demand has led to a critical question for many: **are diabetics struggle to get Ozempic?**

After a surge in demand that saw prescription fills for semaglutide increase by 442% between January 2021 and December 2023, many patients are asking: How long until Ozempic is back in stock? [1.2.1] As of February 2025, the FDA has officially declared the shortage resolved [1.2.2].

Recent drug shortage reports from health authorities like Health Canada indicate multiple betahistine products have experienced significant supply disruptions. Patients relying on this medication for conditions like Meniere's disease are facing challenges understanding why there is a shortage of betahistine and what steps they can take to manage their condition.

According to the American Society of Health-System Pharmacists (ASHP), several manufacturers of dorzolamide ophthalmic solution have recently experienced supply issues, leading many to ask: **Is there a dorzolamide shortage?**.

In December 2024, the U.S. Food and Drug Administration (FDA) officially determined that the national shortage for tirzepatide was resolved, yet with demand remaining high for brand names like Mounjaro and Zepbound, many patients are asking: **will tirzepatide go back on the shortage list?**.

The U.S. Food and Drug Administration (FDA) officially determined that the shortage of tirzepatide injections was resolved in December 2024, after nearly two years of supply issues due to overwhelming demand. This definitive end to the **tirzepatide shortage** carries significant implications for patients, providers, and the compounding pharmacy industry.

Triamcinolone was the 108th most commonly prescribed medication in the United States in 2023, and despite some specific brand name discontinuations, **is triamcinolone still available**. The answer is yes, though its availability varies depending on the specific form, including topical, nasal, and injectable types.